Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

Become a member
  1. OncologyPRO
  2. Meeting Resources
  3. ESMO Gastrointestinal Cancers Congress 2024

Bristol Myers Squibb - Evolving clinical landscape in GI cancer: Immuno-oncology and novel therapies

Advances in the treatment of MSI-H/dMMR and KRAS G12C mutated mCRC

Date

28 Jun 2024

Session

Bristol Myers Squibb - Evolving clinical landscape in GI cancer: Immuno-oncology and novel therapies

Presenters

Sebastian Stintzing

Authors

S. Stintzing

Author affiliations

  • Charité - Universitätsmedizin Berlin, Berlin/DE

Resources

This content is available to ESMO members and event participants.
Login

Resources from the same session

Welcome and introduction

Presenter: Ian Chau

Session: Bristol Myers Squibb - Evolving clinical landscape in GI cancer: Immuno-oncology and novel therapies

Resources:

Webcast

Q&A, summary, and meeting closure

Presenter: Ian Chau

Session: Bristol Myers Squibb - Evolving clinical landscape in GI cancer: Immuno-oncology and novel therapies

Resources:

Webcast

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings

  • Necessary cookies enable core functionality. The website cannot function properly without these cookies, and you can only disable them by changing your browser preferences.